Description
Human Normal Immunoglobulin is used to treat the following conditions:
-
Patients with primary hematopoietic immunodeficiency (PI) who are two years of age or older. This encompasses several conditions such as congenital agammaglobulinemia, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, severe combination immunodeficiencies, and common variable immunodeficiency.
-
Idiopathic Thrombocytopenic Purpura (ITP): to increase platelet counts to stop bleeding or to enable surgery for a patient with ITP.Â
-
The goals of maintenance therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) are to reduce neuromuscular dysfunction and disability and to avoid relapses.